Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study.
Riccardo CandidoMonica ModugnoMonica LarosaMaria Chiara RossiAntonio NicolucciEnrico Gabellierinull nullPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
In adults with T2D, effectiveness and safety of iGlarLixi were documented in a real-world setting; appropriateness of use and adequate titration should be urgently improved so that clinical practice outcomes become more comparable to clinical trials results. Further real-world studies on the effect of iGlarLixi therapy are warranted.